MIGUEL ÁNGEL
POZO GARCÍA
Catedrático de universidad
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (9)
2017
-
Effects of a sativex-like combination of phytocannabinoids on disease progression in R6/2 mice, an experimental model of huntington’s disease
International Journal of Molecular Sciences, Vol. 18, Núm. 4
-
Insulin regulates astrocytic glucose handling through cooperation with IGF-I
Diabetes, Vol. 66, Núm. 1, pp. 64-74
2016
-
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3
Neuroscience, Vol. 339, pp. 191-209
-
The insulin-like growth factor I receptor regulates glucose transport by astrocytes
GLIA, Vol. 64, Núm. 11, pp. 1962-1971
2014
-
A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain
Current Alzheimer Research, Vol. 11, Núm. 2, pp. 175-181
-
Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging
Journal of Alzheimer's Disease, Vol. 40, Núm. S1
2013
-
Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of parkinson's disease
CNS and Neurological Disorders - Drug Targets, Vol. 12, Núm. 5, pp. 665-679
2012
-
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Journal of Neuroinflammation, Vol. 9
2011
-
Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Núm. 12, pp. 2228-2237